Suppr超能文献

一例罕见的慢性粒细胞白血病病例,存在费城染色体、BCR-ABL e13a3转录本以及涉及四条不同染色体的复杂易位。

A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes.

作者信息

Achkar Walid Al, Wafa Abdulsamad, Ali Bashar Yousef, Manvelyan Marina, Liehr Thomas

机构信息

Molecular Biology and Biotechnology Department, Human Genetics Division, Atomic Energy Commission, Damascus, Syria.

出版信息

Oncol Lett. 2010 Sep;1(5):797-800. doi: 10.3892/ol_00000139. Epub 2010 Sep 1.

Abstract

The so-called Philadelphia (Ph) chromosome is present in more than 90% of chronic myeloid leukemia (CML) patients. Around 5-10% of these patients show complex translocations involving other chromosomes in addition to and/or besides chromosomes 9 and 22. CML cases with fusion transcripts, such as e13a3, in which ABL exon 3 rather than exon 2 has fused to BCR, are extremely rare. Such reported cases with the e13a3 transcript showed the Ph chromosome on karyotype analysis. This study reported a rare Ph chromosome-positive CML case with new complex chromosomal aberrations and an e13a3 BCR-ABL transcript that has yet to be established. A four-chromosome translocation involving chromosomal regions 12p11.2, 19q13.3, 9q34.1 and 22q11.2, besides a trisomy 8 and a derivative chromosome 12, were identified using high resolution multicolor banding. Reverse transcription polymerase chain reaction products showed the presence of BCR-ABL fusion transcript e13a3, and this signifies the major BCR breakpoint. The significance of the observed rearrangements and their possible role in the progression of CML was investigated.

摘要

所谓的费城(Ph)染色体存在于超过90%的慢性髓性白血病(CML)患者中。这些患者中约5-10%除了9号和22号染色体之外和/或还显示涉及其他染色体的复杂易位。具有融合转录本的CML病例,如e13a3,其中ABL外显子3而非外显子2与BCR融合,极为罕见。此类报道的具有e13a3转录本的病例在核型分析中显示有Ph染色体。本研究报告了一例罕见的Ph染色体阳性CML病例,伴有新的复杂染色体畸变以及尚未见报道的e13a3 BCR-ABL转录本。使用高分辨率多色带技术鉴定出除8号染色体三体和一条衍生的12号染色体外,还存在涉及染色体区域12p11.2、19q13.3、9q34.1和22q11.2的四染色体易位。逆转录聚合酶链反应产物显示存在BCR-ABL融合转录本e13a3,这表明存在主要的BCR断裂点。研究了观察到的重排的意义及其在CML进展中的可能作用。

相似文献

2
A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.
Int J Hematol. 2009 Sep;90(2):230-234. doi: 10.1007/s12185-009-0368-4. Epub 2009 Jun 30.
3
Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
J Cancer Res Clin Oncol. 2011 Sep;137(9):1329-36. doi: 10.1007/s00432-011-1002-4. Epub 2011 Jul 8.
4
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
Acta Haematol. 2002;107(2):76-94. doi: 10.1159/000046636.
10
Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
Med Oncol. 2013 Mar;30(1):348. doi: 10.1007/s12032-012-0348-z. Epub 2012 Dec 27.

引用本文的文献

2
Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations.
Anal Cell Pathol (Amst). 2021 Aug 12;2021:4909012. doi: 10.1155/2021/4909012. eCollection 2021.
3
6
Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.
Ann Lab Med. 2016 May;36(3):287-9. doi: 10.3343/alm.2016.36.3.287.
7
Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.
Med Oncol. 2015 Feb;32(2):452. doi: 10.1007/s12032-014-0452-3. Epub 2015 Jan 13.
8
Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities.
J Cell Mol Med. 2014 Jul;18(7):1239-46. doi: 10.1111/jcmm.12319. Epub 2014 Jun 9.

本文引用的文献

2
A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.
Int J Hematol. 2009 Sep;90(2):230-234. doi: 10.1007/s12185-009-0368-4. Epub 2009 Jun 30.
3
Molecular definition of high-resolution multicolor banding probes: first within the human DNA sequence anchored FISH banding probe set.
J Histochem Cytochem. 2008 May;56(5):487-93. doi: 10.1369/jhc.2008.950550. Epub 2008 Feb 5.
7
CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall.
Blood. 2002 Aug 1;100(3):1092-3. doi: 10.1182/blood-2002-03-0930.
8
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
Acta Haematol. 2002;107(2):76-94. doi: 10.1159/000046636.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验